{"id":322617,"date":"2026-10-22T10:30:26","date_gmt":"2026-10-22T05:00:26","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/?p=322617"},"modified":"2026-10-22T10:30:26","modified_gmt":"2026-10-22T05:00:26","slug":"why-biocon-ltd-share-near-52-week-consecutive-low-2026","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/why-biocon-ltd-share-near-52-week-consecutive-low-2026\/","title":{"rendered":"Biocon 52 Week Low Streak: Biocon Ltd. (BIOCON) Trades Near One-Year Low Again"},"content":{"rendered":"<div class=\"univest-blue-summary\" style=\"border-left:4px solid #1F4E79;background:#EBF3FB;padding:12px 16px;margin:0 0 18px 0;font-style:italic;\"><em><a href=\"https:\/\/univest.in\/stocks\/biocon\/biocon-ltd-share-price-today\">Biocon Ltd. (BIOCON)<\/a> share price is trading within 2% of its 52-week low today and stood at Rs 332.55, down 0.28% from the previous close. Market cap was Rs 55,491.09 crore.<\/em><\/div>\n<p style=\"margin-top:0!important;\">Biocon Ltd. (BIOCON) has now traded within 2% of its 52-week low for its second straight session, extending a two-session pattern that shows a cumulative decline of 2.33% across the streak. At 10:22 AM IST, the stock was trading at Rs 332.55, with the day\u2019s low at Rs 328.65. The latest Univest data confirms this repeated-low pattern, but it does not establish a company-specific cause for the continued move.<\/p>\n<p>The previous close was Rs 333.50, while the stock opened at Rs 335.90 and also touched the same level as the day high. Biocon\u2019s market capitalisation stood at Rs 55,491.09 crore. For readers tracking the <strong>Biocon 52 Week Low Streak<\/strong>, the key point is not a one-off intraday move but the persistence of weakness across back-to-back sessions, which keeps the share price near its yearly low zone.<\/p>\n<div id=\"ez-toc-container\" class=\"ez-toc-v2_0_65 counter-hierarchy ez-toc-counter ez-toc-grey ez-toc-container-direction\">\n<div class=\"ez-toc-title-container\">\n<p class=\"ez-toc-title \" >Table of Contents<\/p>\n<span class=\"ez-toc-title-toggle\"><a href=\"#\" class=\"ez-toc-pull-right ez-toc-btn ez-toc-btn-xs ez-toc-btn-default ez-toc-toggle\" aria-label=\"Toggle Table of Content\"><span class=\"ez-toc-js-icon-con\"><span class=\"\"><span class=\"eztoc-hide\" style=\"display:none;\">Toggle<\/span><span class=\"ez-toc-icon-toggle-span\"><svg style=\"fill: #999;color:#999\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" class=\"list-377408\" width=\"20px\" height=\"20px\" viewBox=\"0 0 24 24\" fill=\"none\"><path d=\"M6 6H4v2h2V6zm14 0H8v2h12V6zM4 11h2v2H4v-2zm16 0H8v2h12v-2zM4 16h2v2H4v-2zm16 0H8v2h12v-2z\" fill=\"currentColor\"><\/path><\/svg><svg style=\"fill: #999;color:#999\" class=\"arrow-unsorted-368013\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"10px\" height=\"10px\" viewBox=\"0 0 24 24\" version=\"1.2\" baseProfile=\"tiny\"><path d=\"M18.2 9.3l-6.2-6.3-6.2 6.3c-.2.2-.3.4-.3.7s.1.5.3.7c.2.2.4.3.7.3h11c.3 0 .5-.1.7-.3.2-.2.3-.5.3-.7s-.1-.5-.3-.7zM5.8 14.7l6.2 6.3 6.2-6.3c.2-.2.3-.5.3-.7s-.1-.5-.3-.7c-.2-.2-.4-.3-.7-.3h-11c-.3 0-.5.1-.7.3-.2.2-.3.5-.3.7s.1.5.3.7z\"\/><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n<nav><ul class='ez-toc-list ez-toc-list-level-1 ' ><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-1\" href=\"https:\/\/univest.in\/blogs-2\/why-biocon-ltd-share-near-52-week-consecutive-low-2026\/#Biocon_52_Week_Low_Streak_Consecutive_Low_Analysis\" title=\"Biocon 52 Week Low Streak: Consecutive Low Analysis\">Biocon 52 Week Low Streak: Consecutive Low Analysis<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-2\" href=\"https:\/\/univest.in\/blogs-2\/why-biocon-ltd-share-near-52-week-consecutive-low-2026\/#What_the_Repeated_52-Week_Lows_Show\" title=\"What the Repeated 52-Week Lows Show\">What the Repeated 52-Week Lows Show<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-3\" href=\"https:\/\/univest.in\/blogs-2\/why-biocon-ltd-share-near-52-week-consecutive-low-2026\/#Biocon_Ltd_BIOCON_Fundamental_Analysis\" title=\"Biocon Ltd. (BIOCON) Fundamental Analysis\">Biocon Ltd. (BIOCON) Fundamental Analysis<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-4\" href=\"https:\/\/univest.in\/blogs-2\/why-biocon-ltd-share-near-52-week-consecutive-low-2026\/#Sector_and_Industry_Context\" title=\"Sector and Industry Context\">Sector and Industry Context<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-5\" href=\"https:\/\/univest.in\/blogs-2\/why-biocon-ltd-share-near-52-week-consecutive-low-2026\/#Peer_Comparison\" title=\"Peer Comparison\">Peer Comparison<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-6\" href=\"https:\/\/univest.in\/blogs-2\/why-biocon-ltd-share-near-52-week-consecutive-low-2026\/#Why_Investors_Are_Watching\" title=\"Why Investors Are Watching\">Why Investors Are Watching<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-7\" href=\"https:\/\/univest.in\/blogs-2\/why-biocon-ltd-share-near-52-week-consecutive-low-2026\/#About_the_Company\" title=\"About the Company\">About the Company<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-8\" href=\"https:\/\/univest.in\/blogs-2\/why-biocon-ltd-share-near-52-week-consecutive-low-2026\/#Frequently_Asked_Questions\" title=\"Frequently Asked Questions\">Frequently Asked Questions<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-9\" href=\"https:\/\/univest.in\/blogs-2\/why-biocon-ltd-share-near-52-week-consecutive-low-2026\/#What_does_Biocon_52_Week_Low_Streak_mean\" title=\"What does Biocon 52 Week Low Streak mean?\">What does Biocon 52 Week Low Streak mean?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-10\" href=\"https:\/\/univest.in\/blogs-2\/why-biocon-ltd-share-near-52-week-consecutive-low-2026\/#How_long_has_Biocon_stayed_near_its_52-week_low\" title=\"How long has Biocon stayed near its 52-week low?\">How long has Biocon stayed near its 52-week low?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-11\" href=\"https:\/\/univest.in\/blogs-2\/why-biocon-ltd-share-near-52-week-consecutive-low-2026\/#What_is_the_cumulative_move_in_the_Biocon_52_Week_Low_Streak\" title=\"What is the cumulative move in the Biocon 52 Week Low Streak?\">What is the cumulative move in the Biocon 52 Week Low Streak?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-12\" href=\"https:\/\/univest.in\/blogs-2\/why-biocon-ltd-share-near-52-week-consecutive-low-2026\/#How_is_Biocon_priced_versus_sector_peers\" title=\"How is Biocon priced versus sector peers?\">How is Biocon priced versus sector peers?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-13\" href=\"https:\/\/univest.in\/blogs-2\/why-biocon-ltd-share-near-52-week-consecutive-low-2026\/#Why_is_Biocon_Share_Price_being_watched_closely\" title=\"Why is Biocon Share Price being watched closely?\">Why is Biocon Share Price being watched closely?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-14\" href=\"https:\/\/univest.in\/blogs-2\/why-biocon-ltd-share-near-52-week-consecutive-low-2026\/#What_fundamentals_stand_out_in_Biocon_Stock_Analysis\" title=\"What fundamentals stand out in Biocon Stock Analysis?\">What fundamentals stand out in Biocon Stock Analysis?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-15\" href=\"https:\/\/univest.in\/blogs-2\/why-biocon-ltd-share-near-52-week-consecutive-low-2026\/#What_should_investors_monitor_next_in_Biocon_Stock_News\" title=\"What should investors monitor next in Biocon Stock News?\">What should investors monitor next in Biocon Stock News?<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-16\" href=\"https:\/\/univest.in\/blogs-2\/why-biocon-ltd-share-near-52-week-consecutive-low-2026\/#Track_Biocon_Ltd_BIOCON_Share_Price_on_Univest\" title=\"Track Biocon Ltd. (BIOCON) Share Price on Univest\">Track Biocon Ltd. (BIOCON) Share Price on Univest<\/a><\/li><\/ul><\/nav><\/div>\n<h2><span class=\"ez-toc-section\" id=\"Biocon_52_Week_Low_Streak_Consecutive_Low_Analysis\"><\/span><strong>Biocon 52 Week Low Streak: Consecutive Low Analysis<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table style=\"width:100%;border-collapse:collapse;margin:16px 0 22px 0;\">\n<tr>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Metric<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Value<\/th>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Current Price<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 332.55<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Previous Close<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 333.5<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Today&#39;s Move<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs -0.95 (-0.28%)<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Open<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 335.9<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>High<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 335.9<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Low<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 328.65<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Market Capitalisation<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 55,491.09 crore<\/td>\n<\/tr>\n<\/table>\n<p>Biocon Ltd. (BIOCON) traded at Rs 332.55 versus the previous close of Rs 333.5, a fall of 0.28%. The stock opened at Rs 335.9, reached a high of Rs 335.9, touched a low of Rs 328.65.<\/p>\n<p>Biocon share price today was under mild pressure in early trade, with the stock last traded at Rs 332.55, down Rs 0.95 or 0.28% from the previous close of Rs 333.50. The move kept BIOCON close to the lower end of the day\u2019s range after opening at Rs 335.90 and touching a high of Rs 335.90 before slipping to a low of Rs 328.65. That range places the current price much nearer the day\u2019s lower band than the upper band.<\/p>\n<p>The market capitalisation of Rs 55,491.09 crore keeps Biocon in the conversation among large listed healthcare names, but the short-term price behaviour is clearly weak. In the context of a <strong>Biocon 52 Week Low Streak<\/strong>, today\u2019s movement matters less as a standalone session and more as part of the repeated pattern of trading near the one-year trough. For investors following <strong>Biocon Share Price<\/strong>, the focus stays on whether the stock can move away from this low zone or continue drifting around it.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"What_the_Repeated_52-Week_Lows_Show\"><\/span><strong>What the Repeated 52-Week Lows Show<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>The <strong>Biocon 52 Week Low Streak<\/strong> now spans two consecutive trading sessions, and the cumulative 2.33% decline across that period is the central data point to watch. This tells readers that BIOCON has not merely faced one isolated weak day; it has remained near its 52-week trough across multiple sessions. That repeated pattern is more important than the small day-to-day change because it reflects persistent price weakness around the same low area.<\/p>\n<p>At the same time, the available data confirms the price pattern but does not identify a company-specific trigger. That is a crucial distinction for any <strong>Biocon Stock News<\/strong> update. The stock is trading close to its 52-week low again, but the numbers alone do not prove whether the move is being shaped by sentiment, company expectations, sector behaviour or broader market caution. For a reader following <strong>Biocon Share Price Update<\/strong>, the factual takeaway is that the downside has continued long enough to merit attention, even without a confirmed catalyst.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Biocon_Ltd_BIOCON_Fundamental_Analysis\"><\/span><strong>Biocon Ltd. (BIOCON) Fundamental Analysis<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table style=\"width:100%;border-collapse:collapse;margin:16px 0 22px 0;\">\n<tr>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Metric<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Value<\/th>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Market Capitalisation<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 55,491.09 crore<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>P\/E Ratio<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">109.73x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>P\/B Ratio<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">1.6x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>ROE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">1.35%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>ROCE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">3.26%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>EPS<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 3.04<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Book Value Per Share<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 208.53<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Dividend Yield<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">0.15%<\/td>\n<\/tr>\n<\/table>\n<p>Biocon Ltd. (BIOCON) fundamental metrics show P\/E 109.73x, P\/B 1.6x, ROE 1.35%, ROCE 3.26%. These figures provide context only and are not a buy or sell signal.<\/p>\n<p>Biocon Ltd. has a market capitalisation of Rs 55,491.09 crore, which gives readers a sense of company size before judging valuation. On valuation, P\/E at 109.73x, P\/B at 1.6x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 1.35% and ROCE of 3.26%, helping investors compare shareholder returns and capital efficiency. According to latest Univest data, additional metrics include EPS of Rs 3.04, book value per share of Rs 208.53, dividend yield of 0.15%, adding context to earnings, balance-sheet value and historical payout. Against the latest Univest same industry benchmark, these figures can be compared with benchmark median P\/E of 26.67x, median ROE of 11.33%, median ROCE of 13.25%. These numbers explain the fundamental backdrop without converting the article into a buy or sell view.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Sector_and_Industry_Context\"><\/span><strong>Sector and Industry Context<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table style=\"width:100%;border-collapse:collapse;margin:16px 0 22px 0;\">\n<tr>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Metric<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Value<\/th>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Sector<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Healthcare<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Industry<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Pharmaceuticals &amp; Drugs<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Scope<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">same industry<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company P\/E Ratio<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">109.73x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median P\/E<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">26.67x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Average P\/E<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">38.42x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark P\/E Range<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">0x to 616.23x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company P\/B Ratio<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">1.6x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median P\/B<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">2.7x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company ROE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">1.35%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median ROE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">11.33%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company ROCE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">3.26%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median ROCE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">13.25%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company Market Capitalisation<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 55,491.09 crore<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median Market Cap<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 768.75 crore<\/td>\n<\/tr>\n<\/table>\n<p>Biocon Ltd. (BIOCON) is classified under sector: Healthcare and industry: Pharmaceuticals &amp; Drugs.<\/p>\n<p>Biocon Ltd. (BIOCON) has a P\/E ratio of 109.73x, which is above the benchmark median of 26.67x, a difference of +311.44%. P\/E is a valuation multiple and is not, by itself, a buy or sell signal.<\/p>\n<p>Biocon Ltd. (BIOCON) has a ROE of 1.35%, which is below the benchmark median of 11.33%, a difference of -88.08%. Biocon Ltd. (BIOCON) has a ROCE of 3.26%, which is below the benchmark median of 13.25%, a difference of -75.4%.<\/p>\n<p>Track stocks falling to yearly lows through the <a href=\"https:\/\/univest.in\/screeners\/52-week-low\">Univest 52-week-low screener<\/a>. The peer table below provides the company-level comparison.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Peer_Comparison\"><\/span><strong>Peer Comparison<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table style=\"width:100%;border-collapse:collapse;margin:16px 0 22px 0;\">\n<tr>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">Company<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">Symbol<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">Market Cap (Cr)<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">P\/E<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">P\/B<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">ROE (%)<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">ROCE (%)<\/th>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/abbotindia\/abbott-india-ltd-share-price-today\" style=\"color:#0645AD;text-decoration:underline;\"><strong>Abbott India Ltd.<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">ABBOTINDIA<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">54,909.79<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">33.88<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">10.57<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">34.67<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">46.72<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/alkem\/alkem-laboratories-ltd-share-price-today\" style=\"color:#0645AD;text-decoration:underline;\"><strong>Alkem Laboratories Ltd.<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">ALKEM<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">59,722.72<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">27.52<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">4.15<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">18.29<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">21.28<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><strong>Gland Pharma Ltd.<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">GLAND<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">49,952.91<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">42.75<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">4.54<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">10.56<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">14.96<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/glenmark\/glenmark-pharmaceuticals-ltd-share-price-today\" style=\"color:#0645AD;text-decoration:underline;\"><strong>Glenmark Pharmaceuticals Ltd.<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">GLENMARK<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">62,339.2<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">34.61<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">5.68<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">14.1<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">20.35<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/ipcalab\/ipca-laboratories-ltd-share-price-today\" style=\"color:#0645AD;text-decoration:underline;\"><strong>Ipca Laboratories Ltd.<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">IPCALAB<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">46,049.85<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">37.13<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">5.73<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">15.88<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">19.41<\/td>\n<\/tr>\n<\/table>\n<p>Biocon Ltd. (BIOCON) has a P\/E ratio of 109.73x compared with the displayed peer median of 34.61x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 1.35% compares with a peer median of 15.88% across the companies shown in the table. ROCE stood at 3.26% versus the displayed peer median of 20.35%, providing a capital-efficiency comparison. Biocon Ltd. (BIOCON) has a market capitalisation of Rs 55,491.09 crore. Among the 5 peers shown, 2 have a larger market capitalisation.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Why_Investors_Are_Watching\"><\/span><strong>Why Investors Are Watching<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<ul>\n<li>The <strong>Biocon 52 Week Low Streak<\/strong> has now run for two straight sessions, keeping the stock near its one-year low zone.<\/li>\n<li>The cumulative decline across the streak is 2.33%, which is more informative than the single-session change alone.<\/li>\n<li>Biocon\u2019s P\/E of 109.73 is well above the industry median, so valuation remains a key part of the <strong>Biocon Fundamental Analysis<\/strong> debate.<\/li>\n<li>The company\u2019s ROE of 1.35% and ROCE of 3.26% are materially below the sector benchmark, which keeps the profitability lens in focus.<\/li>\n<li>Investors following <strong>Biocon Stock News<\/strong> may watch whether the share price can move away from the low zone or remain near the yearly trough.<\/li>\n<\/ul>\n<h2><span class=\"ez-toc-section\" id=\"About_the_Company\"><\/span><strong>About the Company<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Biocon Ltd. is a healthcare company in the Pharmaceuticals &amp; Drugs industry. Its market capitalisation stands at Rs 55,491.09 crore, placing it among larger listed names in the sector. The company is tracked on both NSE and BSE, and its share price is closely watched by investors looking at healthcare, earnings quality and valuation.<\/p>\n<p>From a fundamentals angle, Biocon\u2019s current numbers show a stock with a high earnings multiple, a lower price-to-book ratio than many peers, and modest return ratios. That combination helps explain why the <strong>Biocon 52 Week Low Streak<\/strong> has become a useful lens for <strong>Biocon Stock Performance<\/strong> and for anyone following <strong>Biocon Company News<\/strong> in the Indian market.<\/p>\n<div style=\"background:#CC0000;border-radius:8px;padding:16px 20px;margin:24px 0;\">\n<p style=\"color:#FFFFFF;font-size:13px;line-height:1.7;margin:0;\"><strong style=\"color:#FFFFFF;\">Disclaimer:<\/strong> Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Uniresearch Global Pvt. Ltd. (Research Analyst, SEBI Registration Number INH000013776), a subsidiary of Univest Communication Technologies Private Limited.<\/p>\n<\/div>\n<h2><span class=\"ez-toc-section\" id=\"Frequently_Asked_Questions\"><\/span><strong>Frequently Asked Questions<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<h3><span class=\"ez-toc-section\" id=\"What_does_Biocon_52_Week_Low_Streak_mean\"><\/span><strong>What does Biocon 52 Week Low Streak mean?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> It means Biocon Ltd. has traded within 2% of its 52-week low for consecutive sessions. In this case, the streak has lasted two straight sessions, showing repeated trading near the yearly low zone.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"How_long_has_Biocon_stayed_near_its_52-week_low\"><\/span><strong>How long has Biocon stayed near its 52-week low?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Biocon has stayed near its 52-week low for a second straight session. The latest Univest data shows a two-session pattern, which is more meaningful than a single-day dip. The stock moved -0.28% during the session.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_is_the_cumulative_move_in_the_Biocon_52_Week_Low_Streak\"><\/span><strong>What is the cumulative move in the Biocon 52 Week Low Streak?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> The cumulative change across the streak is -2.33%. That figure captures the full two-session move and is the main number to track in this Biocon 52 Week Low Streak update.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"How_is_Biocon_priced_versus_sector_peers\"><\/span><strong>How is Biocon priced versus sector peers?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Biocon\u2019s P\/E ratio of 109.73 is well above the industry median of 26.67. Its P\/B ratio of 1.6 is below the sector median of 2.7, so the valuation picture is mixed rather than simple.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Why_is_Biocon_Share_Price_being_watched_closely\"><\/span><strong>Why is Biocon Share Price being watched closely?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Biocon Share Price is being watched because the stock remains near its yearly low zone for consecutive sessions. Investors often track whether repeated weakness is sustained or whether the price moves away from that area.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_fundamentals_stand_out_in_Biocon_Stock_Analysis\"><\/span><strong>What fundamentals stand out in Biocon Stock Analysis?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Biocon\u2019s low ROE of 1.35% and ROCE of 3.26% stand out most, especially against sector medians. EPS is Rs 3.04, while book value is Rs 208.53, and dividend yield is 0.15%.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_should_investors_monitor_next_in_Biocon_Stock_News\"><\/span><strong>What should investors monitor next in Biocon Stock News?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Investors may watch whether the share price continues to hover near the one-year low zone, and whether the broader fundamental picture changes. The current Biocon 52 Week Low Streak remains a key signal to track.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Track_Biocon_Ltd_BIOCON_Share_Price_on_Univest\"><\/span><strong>Track Biocon Ltd. (BIOCON) Share Price on Univest<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Use <a href=\"https:\/\/univest.in\/stocks\/biocon\/biocon-ltd-share-price-today\">Biocon Ltd. (BIOCON) live share-price page<\/a>, <a href=\"https:\/\/univest.in\/screeners\/52-week-low\">Univest 52-week-low screener<\/a>, <a href=\"https:\/\/univest.in\/blogs\">Univest market blogs<\/a> to review live stock data, yearly-low lists and related market analysis.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Biocon Ltd. Share Price trades near its 52-week low at Rs 332.55, marking a 0.28% decline today. Market cap stands at Rs 55,491.09 crore.<\/p>\n","protected":false},"author":38,"featured_media":322616,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[842],"tags":[],"class_list":["post-322617","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news"],"metadata":{"rank_math_internal_links_processed":["1"],"_thumbnail_id":["322616"],"rank_math_title":["Biocon 52 Week Low Streak: BIOCON Trades Near One-Year Low"],"rank_math_description":["Biocon 52 Week Low Streak: Biocon Ltd. has traded near its 52-week low for a second straight session, with a 2.33% cumulative fall across the streak and weak"],"rank_math_focus_keyword":["Biocon 52 Week Low Streak"],"rank_math_robots":["a:2:{i:0;s:7:\"noindex\";i:1;s:8:\"nofollow\";}"]},"jetpack_sharing_enabled":true,"jetpack_featured_media_url":"https:\/\/univest.in\/blogs-2\/wp-content\/uploads\/2026\/10\/biocon-52-week-low-streak-biocon-ltd-biocon-trades-near-one-year-low-again.webp","_links":{"self":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/322617","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/users\/38"}],"replies":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/comments?post=322617"}],"version-history":[{"count":1,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/322617\/revisions"}],"predecessor-version":[{"id":322618,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/322617\/revisions\/322618"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media\/322616"}],"wp:attachment":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media?parent=322617"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/categories?post=322617"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/tags?post=322617"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}